Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K1OA
|
||||
Former ID |
DIB005715
|
||||
Drug Name |
D-4418
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cutaneous T-cell lymphoma [ICD9: 202.1, 202.2; ICD10:C84.0, C84.1] | Discontinued in Phase 1 | [546370] | ||
Company |
Chiroscience R&D Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H11Cl2N3O2
|
||||
Canonical SMILES |
C(=O)(c1c2c(nccc2)c(cc1)OC)Nc1c(ncc(c1)Cl)Cl
|
||||
CAS Number |
CAS 257892-34-5
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [529616] | |
Type IV phosphodiesterase | Target Info | Inhibitor | [529616] | ||
CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [529616] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
PathWhiz Pathway | Purine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.